ZA200502374B - Use of posaconazole for the treatment of fungal infections - Google Patents

Use of posaconazole for the treatment of fungal infections Download PDF

Info

Publication number
ZA200502374B
ZA200502374B ZA200502374A ZA200502374A ZA200502374B ZA 200502374 B ZA200502374 B ZA 200502374B ZA 200502374 A ZA200502374 A ZA 200502374A ZA 200502374 A ZA200502374 A ZA 200502374A ZA 200502374 B ZA200502374 B ZA 200502374B
Authority
ZA
South Africa
Prior art keywords
posaconazole
treatment
prevention
substance
composition
Prior art date
Application number
ZA200502374A
Other languages
English (en)
Inventor
Courtney Rachel
Mark A Laughlin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA200502374B publication Critical patent/ZA200502374B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200502374A 2002-09-23 2005-03-22 Use of posaconazole for the treatment of fungal infections ZA200502374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41298502P 2002-09-23 2002-09-23

Publications (1)

Publication Number Publication Date
ZA200502374B true ZA200502374B (en) 2006-12-27

Family

ID=32030948

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200502374A ZA200502374B (en) 2002-09-23 2005-03-22 Use of posaconazole for the treatment of fungal infections

Country Status (11)

Country Link
US (1) US20040058974A1 (es)
EP (1) EP1542681A2 (es)
JP (1) JP2006503839A (es)
CN (1) CN1688306A (es)
AU (1) AU2003282806A1 (es)
BR (1) BR0314763A (es)
CA (1) CA2499897A1 (es)
MX (1) MXPA05003124A (es)
NO (1) NO20051987L (es)
WO (1) WO2004026303A2 (es)
ZA (1) ZA200502374B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7406092B2 (en) * 2003-07-21 2008-07-29 Qlogic, Corporation Programmable pseudo virtual lanes for fibre channel systems
GB0409077D0 (en) 2004-04-23 2004-05-26 Neutec Pharma Plc Treatment of fungal infections
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
CN102499928A (zh) 2004-08-13 2012-06-20 先灵-普劳有限公司 包含抗菌素、三唑和皮质类固醇的药物制剂
SG170047A1 (en) * 2006-05-30 2011-04-29 Elan Pharma Int Ltd Nanoparticulate posaconazole formulations
EP2303026B1 (en) 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8975310B2 (en) 2011-07-20 2015-03-10 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
JP6051230B2 (ja) 2011-12-21 2016-12-27 ブリガム ヤング ユニバーシティ 口腔ケア組成物
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP3225113B1 (en) 2012-05-02 2020-09-02 Brigham Young University Methods for making ceragenin particulate materials
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
WO2014062960A1 (en) 2012-10-17 2014-04-24 Brigham Young University Treatment and prevention of mastitis
CA2897150C (en) 2013-01-07 2021-07-13 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
RU2669800C2 (ru) 2013-03-15 2018-10-16 Брихэм Янг Юниверсити Способы лечения воспаления, аутоиммунных расстройств и боли
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) * 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
US9527883B2 (en) 2015-04-22 2016-12-27 Brigham Young University Methods for the synthesis of ceragenins
WO2016172543A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity

Also Published As

Publication number Publication date
JP2006503839A (ja) 2006-02-02
WO2004026303A3 (en) 2004-04-29
CA2499897A1 (en) 2004-04-01
CN1688306A (zh) 2005-10-26
EP1542681A2 (en) 2005-06-22
MXPA05003124A (es) 2005-06-22
WO2004026303A2 (en) 2004-04-01
BR0314763A (pt) 2005-07-26
US20040058974A1 (en) 2004-03-25
AU2003282806A1 (en) 2004-04-08
NO20051987L (no) 2005-04-22

Similar Documents

Publication Publication Date Title
ZA200502374B (en) Use of posaconazole for the treatment of fungal infections
Terrell Antifungal agents. Part II. The azoles
KR101834024B1 (ko) 치환된 베타―시클로덱스트린에 의해 안정화된 포사코나졸 정맥내 용액 제제
HUE027184T2 (en) Combination of azelastine and cyclesonide
JP2009527465A (ja) 筋骨格障害およびそれに関連する症状の処置のための方法、組成物およびキット
EP2846780B1 (en) Solubilized capsule formulation of 1,1-dimethylethyl [(1s)-1-{[(2s,4r)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1r,2s)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate
JP2020535227A5 (es)
CN106999461A (zh) 选择性s1p1受体激动剂的给药方案
JP2004527525A (ja) 増大したバイオアベイラビリティーを有する抗真菌組成物
Cowart et al. A phase 1 randomized study of single intravenous infusions of the novel nitroxyl donor BMS‐986231 in healthy volunteers
Hay et al. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole
CN116685353A (zh) 血管性水肿的预防和治疗
IL299568A (en) A combination of zibutantan and dapagliflozin for the treatment of chronic kidney disease
CN102805731A (zh) 泊沙康唑干混悬剂及其制备方法
McManus et al. Antifungal drugs
JP2915296B2 (ja) 抗真菌製剤
CN101879169B (zh) 一种治疗血管相关疾病的复方制剂及其制备方法
US20060141028A1 (en) Cyclosporin formulations
CN117545477A (zh) Mmp-12抑制剂的安全施用
AU2016259775A1 (en) Cabazitaxel and its use for treating cancer
Tablets et al. PrAPO-SAXAGLIPTIN
CA3206840A1 (en) Methods of treatment
JPWO2014188729A1 (ja) 経口用組成物
CA2812968A1 (en) Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
Cesaro Share this story: RELATED ARTICLES